New Jersey: Bill Filed to Add PTSD as Qualifying Medical Cannabis Condition
A proposal to add post traumatic stress disorder (PTSD) to the list of conditions that qualifies someone to become a medical cannabis patient was filed this week in New Jersey. Assembly Bill 3726, which has been assigned to the Assembly Health and Senior Services Committee, is sponsored by Assemblymembers Vincent Mazzeo and Linda Stender.
The move would be in line with a plethora of recent science which has found that cannabis, or the compounds within it, are helpful in treating PTSD.
For example: In November, a government-funded study using human trials found that “the cannabinoid system may serve as a promising target for innovative intervention strategies (e.g. pharmacological enhancement of exposure-based therapy) in PTSD and other fear learning-related disorders.”
A study published in June in the journal Neuropsychopharmacology came to a similar conclusion, finding that cannabinoids may treat post traumatic stress disorder.
According to the National Institute of Health, PTSD affects about 7.7 million people.